Oracle Biosciences Awarded $1 Million for Cancer Research

Category : Investments
Posted on: February 4, 2014

A Carle physician has received a $1 million grant from the National Cancer Institute to study a diagnostic test that could help identify the often deadly triple negative breast cancer earlier. Dr. Partha Ray, a Carle surgical oncologist, will focus on the FOXC1 gene, a diagnostic and prognostic biomarker for basal-like breast cancer, a particularly deadly form of triple negative breast cancer.The National Cancer Institute awarded the grant to Oracle Biosciences LLC, Dr. Partha Ray’s biotech company, which has laboratory facilities at EnterpriseWorks incubator at the Research Park.$1-million-grant-for-canc.aspx